Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1833-1843
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1833
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1833
Table 2 Clinical outcomes
| Endpoint | Value |
| Technical success, n (%) | 18 (100) |
| Clinical success, n (%) | 18 (100) |
| Periprocedural complications, n (%) | 1 (5.5) |
| Stent-related complications, n (%) | 5 (27.7) |
| Stent occlusion, n (%) | 1 (5.5) |
| Stent migration, n (%) | 1 (5.5) |
| Mean procedural duration min | 81.5 ± 32.2 |
| Median stent patency days (range) | 169 (93-315) |
| Overall mortality, n (%) | 4 (22.2) |
- Citation: Cortese F, Acquafredda F, Mardighian A, Zurlo MT, Ferraro V, Memeo R, Spiliopoulos S, Inchingolo R. Percutaneous insertion of a novel dedicated metal stent to treat malignant hilar biliary obstruction. World J Gastrointest Oncol 2022; 14(9): 1833-1843
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1833.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1833